Viewing nowSingulair Max Orally Disintegrating Tablet 5 mg (Montelukast Sodium)
Montelukast Sodium 5.2mg
Orally disintegrating Tablet · Prescription medication
JW Pharmaceutical Corp.

MFDS item code 200908368 · Notified 2009.11.30
Prevention and continuous treatment of asthma; relief of allergic rhinitis symptoms
This medication helps to prevent and continuously treat asthma. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis.
This medication is taken once daily. Patients with asthma should take it in the evening, while patients with allergic rhinitis should take it at a time determined according to their condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Take this medication 1 hour before or 2 hours after a meal.
Children aged 6~14 years: Place montelukast 5 mg on the tongue once daily and take without water after it disintegrates.
This medicine contains the artificial sweetener aspartame; therefore, patients with the genetic disorder phenylketonuria should not take it. The daily intake of aspartame should be limited to below the WHO recommended amount, and adults can take a maximum of 2.4 grams per day. Patients who are allergic to this medication or are hypersensitive to any of its components should not use it. Additionally, since it contains lactose, it should not be administered to patients with genetic issues such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. This medication is not used as a treatment for acute asthma attacks, and patients should always have separate emergency medication ready in case of asthma exacerbation. While taking this medication, neuropsychiatric symptoms such as anxiety, depression, hallucinations, and suicidal thoughts may occur; immediately consult a doctor if these symptoms arise. Do not use this medication alone for treatment of exercise-induced bronchoconstriction; continue using inhaled beta-agonists and have them ready for emergencies. Patients sensitive to aspirin should not take aspirin or non-steroidal anti-inflammatory drugs while taking this medication; it has not been determined if this drug treats bronchoconstriction in patients with aspirin-sensitive asthma. During the course of this medication, rare side effects such as eosinophilia or vasculitis may occur, so the doctor should closely monitor the patient's symptoms. No specific interactions have been reported when used with other medications, but careful observation is required when used with strong liver enzyme inducers such as phenobarbital, rifampicin, and phenytoin. It should only be administered during pregnancy if the necessity is clear, and caution is needed while breastfeeding. In children, especially infants under 6 months, safety and efficacy have not been established, so use should be avoided. In the case of overdose, there is no specific antidote; general symptomatic treatment and clinical monitoring are required. This medication is sensitive to light, so it should be opened immediately before use and should be taken right after opening while keeping it out of reach of children. Lastly, this medication should be continually taken even when there are no asthma symptoms, and if symptoms worsen or if the use of emergency medication increases compared to usual, immediately consult a doctor.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a dark place. Also, to maintain the effectiveness of the medicine, it is important to store it in a cool room temperature, between 1 and 30 degrees Celsius.
Light pink round orally disintegrating tablet
28 tablets (7 tablets/PTP x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 5.2mg
Orally disintegrating Tablet · Prescription medication
JW Pharmaceutical Corp.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.